T1	Treatment 0 33	Synthetic serum substitute (SSS):
T2	Treatment 360 370	Plasmatein
T3	Treatment 421 431	Plasmanate
T4	Treatment 536 766	divided and cultured in human tubal fluid medium (HTF) supplemented with either HSA (5 mg/mL) or Plasmatein (10%, v/v; 5 mg/ml) as a means of indirectly assessing the effect alpha- and beta-globulins have on embryonic development.
T5	Treatment 835 845	Plasmatein
T6	Treatment 1009 1019	Plasmatein
T7	Treatment 1141 1144	HSA
T8	Treatment 1665 1675	Plasmatein
T9	Treatment 1688 1691	SSS
T10	Treatment 2019 2022	SSS
T11	Treatment 2104 2114	Plasmatein
T12	Treatment 2200 2210	Plasmatein
T13	Treatment 2223 2226	SSS
T14	Treatment 2335 2361	Synthetic serum substitute
